OKUR
Price:
$2.63
Market Cap:
$35.63M
OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
OKUR
According to OnKure Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of OnKure Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), OKUR's Dividend Yield was at its highest in in the March 2023 quarter at 0%. The Dividend Yield was at its lowest in in the March 2023 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of OnKure Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
The current Dividend Yield of OnKure Therapeutics, Inc. (OKUR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
OnKure Therapeutics, Inc.’s Dividend Yield is less than Tempest Therapeutics, Inc. (0%), less than Kezar Life Sciences, Inc. (0%), less than FibroGen, Inc. (0%), less than PDS Biotechnology Corporation (0%), less than Xilio Therapeutics, Inc. (0%), less than Actinium Pharmaceuticals, Inc. (0%), less than Aligos Therapeutics, Inc. (0%), less than Mersana Therapeutics, Inc. (0%), less than Barinthus Biotherapeutics plc (0%), less than CEL-SCI Corporation (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $15.19M | |
| 0% | $45.77M | |
| 0% | $33.37M | |
| 0% | $43.78M | |
| 0% | $38.90M | |
| 0% | $45.23M | |
| 0% | $62.09M | |
| 0% | $137.32M | |
| 0% | $29.44M | |
| 0% | $43.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OnKure Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OnKure Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is OnKure Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for OnKure Therapeutics, Inc. (OKUR)?
What is the highest Dividend Yield for OnKure Therapeutics, Inc. (OKUR)?
What is the 3-year average Dividend Yield for OnKure Therapeutics, Inc. (OKUR)?
What is the 5-year average Dividend Yield for OnKure Therapeutics, Inc. (OKUR)?
How does the current Dividend Yield for OnKure Therapeutics, Inc. (OKUR) compare to its historical average?